Deutsche Bank Downgrades Allscripts (MDRX) to Hold

November 10, 2016 11:31 AM EST
Get Alerts MDRX Hot Sheet
Price: $10.47 -2.42%

Rating Summary:
    14 Buy, 22 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade MDRX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Deutsche Bank downgraded Allscripts (NASDAQ: MDRX) from Buy to Hold with a price target of $11.00 (from $14.00). Analsyt George Hill thinks the Affordable Care Act might be repealed.

"We believe that there is a high likelihood that the Affordable Care Act gets repealed or significantly scaled back, creating uncertainty for provider organizations. As these organizations face a less certain revenue and capex future, we believe that spending on IT is likely to stall until provider organizations know what the next generation set of IT tools needed will look like. Given that outlook, we are downgrading CERN and MDRX shares to Hold given what we expect will be a less certain multi-year outlook for hospital based HCIT spend. While the Ryan plan does call for some investment in medical records, we believe many of these proposals were already covered by the HITECH Act and are unlikely to result in material incremental spending," said Hill.

For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.

Shares of Allscripts closed at $10.25 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Deutsche Bank

Add Your Comment